The New India Assurance Company Fair Value
The New India Assurance Company (NIACL) average fair value is ₹400.0 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹187.66 (+113.15%), fair value range ₹129.59–₹1165.52. Read NIACL ex-dividend dates for the complete payout history and dividend yield track record.
Fair Value Analysis Export
NIACL Fair Value vs Current Price — Valuation Summary
NIACL average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. For live price and a broader fundamental view, visit NIACL screener.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
NIACL Fair Value Analysis — Data Sources & Coverage
The New India Assurance Company financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. Browse NIACL financial statements for revenue, profit, balance sheet and cash flow data.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
NIACL vs Insurance Sector Peers — P/E, P/B & Market Cap
The New India Assurance Company P/E ratio, P/B ratio and market capitalisation vs Insurance sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Go Digit General Insuran… | GODIGIT | 47.01 | 4.97 | ₹23,253 |
| Canara HSBC Life Insuran… | CANHLIFE | 109.93 | 8.82 | ₹14,226 |
| Niva Bupa Health Insuran… | NIVABUPA | 84.51 | 3.88 | ₹15,059 |
| ICICI Prudential Life In… | ICICIPRULI | 42.53 | 5.11 | ₹67,052 |
| HDFC Life Insurance | HDFCLIFE | 58.31 | 5.83 | ₹111,372 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.